Evaluation of the effectiveness of telephone consultations and the level of satisfaction of patients assisted at the Mastology Teacher Assistance Department with this modality during the COVID health emergency
DOI:
https://doi.org/10.29193/RMU.37.4.8Keywords:
COVID-19, SARS-COV-2, BREAST CANCER, PATIENT SATISFACTION, TELEMEDICINEAbstract
Introduction: in March 2020, a national health emergency was declared due to the COVID-19, what resulted in changes in the organization of health services. One of the objectives of this restructure was to minimize in person consultations and to promote telephone consultations. that took place was a reduction in face-to-face consultations (FTFC), and the promotion of telephone consultations (TC).
Objective: to evaluate the effectiveness of telephone consultations and the level of satisfaction of patients assisted at Mastology Department with this modality during the COVID 19 health emergency.
Materials and methods: a survey was used to assess the effectiveness of telephone consultations and the level of satisfaction with this modality.
Results: forty-two patients were surveyed, 69% of which were receiving adjuvant treatment and 14.2% of which were receiving palliative treatment. With regard to the effectiveness of telephone consultations, 76.1% of those surveyed had their need solved by telephone; 78.6% of patients preferred to do the consultation by telephone; 97.6% believed that sufficient time was spent and that the timing of the appointment was appropriate. The responses showed a high level of satisfaction with the care received. The medical care met the expectations of all patients, and 83.3% believed that once the situation went back to normal, telephone consultations would be an option for their requirements.
Conclusion: the telephone consultation method was evaluated with a high level of satisfaction and it allowed health care services to be maintained during the emergency. Although it is early to assess the healthcare impact of telephone consultations and the modality’s capacity to resolve issues, preliminary results show that it is a useful and valuable tool in clinical practice during periods of healthcare emergency.
References
2) Duffy S, Lee TH. In-person health care as option B. N Engl J Med 2018; 378(2):104-6. doi: 10.1056/NEJMp1710735.
3) Lurie N, Carr BG. The role of telehealth in the medical response to disasters. JAMA Intern Med 2018; 178(6):745-6. doi: 10.1001/jamainternmed.2018.1314.
4) Shah MN, Wasserman EB, Gillespie SM, Wood NE, Wang H, Noyes K, et al. High-intensity telemedicine decreases emergency department use for ambulatory care sensitive conditions by older adult senior living community residents. J Am Med Dir Assoc 2015; 16(12):1077-81. doi: 10.1016/j.jamda.2015.07.009.
5) Tsou C, Robinson S, Boyd J, Jamieson A, Blakeman R, Bosich K, et al. Effectiveness and cost-effectiveness of telehealth in rural and remote emergency departments: a systematic review protocol. Syst Rev 2020; 9(1):82. doi:10.1186/s13643-020-01349-y.
6) Wolf I, Waissengrin B, Peles S. Breaking bad news via telemedicine: a new challenge at times of an epidemic. Oncologist 2020; 25(6):e879‐e880. doi:10.1634/theoncologist.2020-0284.
7) Gadzinski AJ, Gore JL, Ellimoottil C, Odisho AY, Watts KL. Implementing telemedicine in response to the COVID-19 pandemic. J Urol 2020; 204(1):14-6. doi:10.1097/JU.0000000000001033.
8) Hollander JE, Carr BG. Virtually perfect? Telemedicine for Covid-19. N Engl J Med 2020; 382(18):1679‐81. doi: 10.1056/NEJMp2003539.
9) Pappot N, Taarnhøj GA, Pappot H. Telemedicine and e-health solutions for COVID-19: patients’ perspective. Telemed J E Health 2020; 26(7):847-9. doi: 10.1089/tmj.2020.0099.
10) Merrell RC, Doarn CR. Telemedicine in the time of the coronavirus. Telemed J E Health 2020; 26(4):375-6. doi:10.1089/tmj.2020.29038.crd.
11) Elkbuli A, Ehrlich H, McKenney M. The effective use of telemedicine to save lives and maintain structure in a healthcare system: current response to COVID-19. Am J Emerg Med 2020; 468-9. doi: 10.1016/j.ajem.2020.04.003.
12) Liang W, Guan W, Chen R, Weng W, Li J, Xu K, et al. Cancer patients in SARS- CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; 21:335-7. doi: 10.1016/S1470-2045(20)30096-6.
13) Yu J, Ouyang W, Chua ML, Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol 2020; 6(7):1108-10. doi: org/10.1001/jamaoncol.2020.0980.